Pfizer Restructuring Expands Shedlarz' Responsibilities As Katen Departs
This article was originally published in The Pink Sheet Daily
Executive Summary
New CEO Jeffrey Kindler also establishes a seven member "Executive Leadership Team."
You may also be interested in...
Pfizer’s Shedlarz To Retire By Year End
Departure of Shedlarz follows several other high-profile exits since CEO Kindler took the helm last year.
Pfizer’s Shedlarz To Retire By Year End
Departure of Shedlarz follows several other high-profile exits since CEO Kindler took the helm last year.
Two Pfizer Veterans To Leave Firm
R&D head LaMattina and CFO Levin have 50 years of experience with Pfizer between them.